Literature DB >> 12884154

Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis.

Thomas L Cherpes1, Leslie A Meyn, Marijane A Krohn, Joel G Lurie, Sharon L Hillier.   

Abstract

A longitudinal cohort study of sexually active women 18-30 years of age was conducted to identify variables associated with the acquisition of herpes simplex virus type 2 (HSV-2) infections. Six hundred seventy HSV-2-seronegative women were followed up at 4-month intervals for 1 year; acquisition of HSV-2 antibodies was detected in 32 of these women. Black race, < or =12 years of education, having a new sex partner, and bacterial vaginosis (BV) were associated with HSV-2 seroconversion on univariate analysis. Antecedent HSV-1 infection was not protective against HSV-2 acquisition. After controlling for other identified risk factors in multivariable models, the diagnosis of BV remained associated with an increased risk of acquiring HSV-2 infection (hazard ratio, 2.1; 95% confidence interval, 1.0-4.5; P=.05). In this study, the population attributable risk of BV for HSV-2 seroconversion was 21%. Additional studies are needed to determine whether screening and treatment of BV could reduce susceptibility to the acquisition of HSV-2 in women.

Entities:  

Mesh:

Year:  2003        PMID: 12884154     DOI: 10.1086/375819

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  141 in total

Review 1.  The microbiota of the vagina and its influence on women's health and disease.

Authors:  David H Martin
Journal:  Am J Med Sci       Date:  2012-01       Impact factor: 2.378

2.  Severity of bacterial vaginosis and the risk of sexually transmitted infection.

Authors:  Jenifer E Allsworth; Jeffrey F Peipert
Journal:  Am J Obstet Gynecol       Date:  2011-02-27       Impact factor: 8.661

Review 3.  Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective.

Authors:  Rebecca M Brotman
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

4.  Vaginal microbiome of reproductive-age women.

Authors:  Jacques Ravel; Pawel Gajer; Zaid Abdo; G Maria Schneider; Sara S K Koenig; Stacey L McCulle; Shara Karlebach; Reshma Gorle; Jennifer Russell; Carol O Tacket; Rebecca M Brotman; Catherine C Davis; Kevin Ault; Ligia Peralta; Larry J Forney
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-03       Impact factor: 11.205

5.  Pyrosequencing of the genital microbiotas of HIV-seropositive and -seronegative women reveals Lactobacillus iners as the predominant Lactobacillus Species.

Authors:  Gregory T Spear; Douglas Gilbert; Alan L Landay; Reza Zariffard; Audrey L French; Pranjal Patel; Patrick M Gillevet
Journal:  Appl Environ Microbiol       Date:  2010-11-12       Impact factor: 4.792

6.  Emerging Sexual Health Issues Among Women Who Have Sex with Women.

Authors:  Jeanne M Marrazzo; Linda M Gorgos
Journal:  Curr Infect Dis Rep       Date:  2012-02-02       Impact factor: 3.725

7.  Dysbiosis-induced IL-33 contributes to impaired antiviral immunity in the genital mucosa.

Authors:  Ji Eun Oh; Byoung-Chan Kim; Dong-Ho Chang; Meehyang Kwon; Sun Young Lee; Dukjin Kang; Jin Young Kim; Inhwa Hwang; Je-Wook Yu; Susumu Nakae; Heung Kyu Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-25       Impact factor: 11.205

Review 8.  Maternal Microbiome and Pregnancy Outcomes That Impact Infant Health: A Review.

Authors:  Anne L Dunlop; Jennifer G Mulle; Erin P Ferranti; Sara Edwards; Alexis B Dunn; Elizabeth J Corwin
Journal:  Adv Neonatal Care       Date:  2015-12       Impact factor: 1.968

9.  Effects of long-term use of nonoxynol-9 on vaginal flora.

Authors:  Courtney A Schreiber; Leslie A Meyn; Mitchell D Creinin; Kurt T Barnhart; Sharon L Hillier
Journal:  Obstet Gynecol       Date:  2006-01       Impact factor: 7.661

10.  Findings associated with recurrence of bacterial vaginosis among adolescents attending sexually transmitted diseases clinics.

Authors:  Rebecca M Brotman; Emily J Erbelding; Roxanne M Jamshidi; Mark A Klebanoff; Jonathan M Zenilman; Khalil G Ghanem
Journal:  J Pediatr Adolesc Gynecol       Date:  2007-08       Impact factor: 1.814

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.